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Background: To report the occurrence of choroidal hypoplasia in the Australian Kelpie breed in Poland, the affected
dogs testing positive for the Collie Eye Anomaly NHEJ1 gene mutation.
Case presentations: Choroidal hypoplasia (CH) was initially diagnosed in a young female Australian Kelpie presented
for routine ophthalmological examination prior to breeding. Indirect ophthalmoscopy revealed tigroid fundi bilaterally
with areas of abnormally arranged choroidal vasculature temporal to the optic disc. These lesions had the appearance
of the choroidal hypoplasia diagnostic for Collie Eye Anomaly, a genetically determined disease seen most commonly
in Collie types.
The DNA based test for the NHEJ1 gene mutation that is confirmatory for Collie Eye Anomaly proved the dog to be
homozygous for this mutation. Twenty one other related dogs were subsequently examined genetically, the dam
proving to be affected and eight others were shown to be carriers.
Conclusions: This report demonstrates that Collie Eye Anomaly is present in a Polish bred Australian Kelpie line and as
such breeders in this country and those importing dogs or semen internationally should be aware of other possible
cases.
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Collie Eye Anomaly (CEA) is a congenital canine pleo-
morphic ocular disease characterized by two main lesions,
choroidal hypoplasia/chorioretinal dysplasia (CH/CRD)
and papillary/peripapillary colobomata. CH/CRD, referred
to as CH in this paper, is characterized by the focal
absence of pigmented choroidal tissue and tapetum tem-
poral to the optic disc and the presence of choroidal blood
vessels abnormal in both appearance and arrangement. If
the lesion also involves part of the non-tapetal fundus the
overlying retinal pigment epithelium lacks pigment. CH is
always bilaterally present, but to varying degrees between
affected dogs and even within the same individual. How-
ever, no matter how extensive, CH appears to be of no
clinical significance in terms of an effect on sight. Colobo-
matous defects can vary considerably in size, the larger
lesions affecting vision and potentially being involved in
post-natal retinal detachment. In addition to these two
features both congenital and post-natal retinal detachment© The Author(s). 2019 Open Access This artic
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although potentially blinding, these features are of low in-
cidence [1–5]. Thus CEA affected dogs can vary from
mildly to moderately affected without vision impairment
or possibly present with partial or total blindness.
A number of studies concerning the genetic background
of the disease have been completed [6–12], one initial
suggestion being that CEA might be inherited as a com-
plex trait involving multiple genetic factors [5]. Subse-
quently it has been shown to be an autosomal recessive
trait in Collie types and Lowe et al. localized a 3.9 - cM
locus associated with CH on chromosome 37 [9]. Fine -
mapping techniques have been used to identify a 7.8 kb
deletion in intron 4 of the NHEJ1 gene(non-homologous
end-joining factor 1), the CEA locus [10]. CH has been
shown to be due to the same NHEJ1 deletion in several
other breeds and a confirmatory genetic test is now com-
mercially available.
CEA was first described as an hereditary disorder in
the Border Collie, Rough and Smooth Collies and the
Shetland Sheepdog [1–5, 13, 14]. It has also been vari-
ously reported in several other breeds including thele is distributed under the terms of the Creative Commons Attribution 4.0
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Fig. 1 Fundus photographs of the affected female to demonstrate
the abnormal arrangement of choroidal vessels in the temporal
tapetal fundus. a Left eye, temporal area, the arrowsdemonstrating
the large area of choroidal hypoplasia. b Right eye, medial area,
demonstrating a normal appearance. c Left eye, temporal area,
demonstrating choroidal hypoplasia
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shire Heeler, the Longhaired Whippet, the Nova Scotia
Duck Tolling Retriever, the Hokkaido dog and the
Silken Windhound [15–20]. A phenotypically identical
lesion has been seen in other non-collie breeds includ-
ing the German Shepherd Dog, Miniature and Toy
Poodles, the Beagle and a mixed-breed dog [17, 18, 20].
The causal genetic defect has not been determined for
all of these breeds.
This is the first published report of CEA in the Austra-
lian Kelpie breed. The initial ophthalmoscopic finding was
subsequently confirmed using the specific DNA based
test. Based on analysis of the probands’ pedigree the dog’s
dam proved to be homozygous for the mutation and one
other affected dog plus several carriers were found.
Case presentation
The initial finding was in a two-and-a-half year old
female Australian Kelpie which was being considered for
breeding purposes. There were no reported visual defi-
cits and performance in a maze test, the menace
response, the pupillary light reflexes and the dazzle re-
flex were all considered to be normal. Biomicroscopic
examination (SL-17 Portable Slit Lamp, Kowa) of the an-
terior segment revealed minor bilateral stromal iridal at-
rophy. Mydriasis was effected using tropicamide
(Tropicamidum WZF 1%, Polfa Warszawa) and fundus
examination completed using direct and indirect oph-
thalmoscopy (Keeler Standard Direct and Keeler Vant-
age Plus Indirect ophthalmoscopes). Fundus imaging
was obtained using a 30D condensing lens (Volk 2) and
photographs were taken using the ClearView Fundus
Camera (Optibrand). Both fundi had a tigroid appear-
ance in the non-tapetal areas, but an irregular arrange-
ment of the choroidal vasculature was observed
bilaterally in the temporal region of the tapetal fundus.
The lesions were easily identifiable with the choroidal
blood vessels being fewer in number and thicker than
normal. The degree of CH allowed the white appearance
of the sclera to be visible between the abnormal blood
vessels (Fig. 1a-c). Colobomatous lesions were not
present and no other ocular abnormalities were found.
Based on the presence of CH a tentative diagnosis of
CEA was suggested, this diagnosis being subsequently
confirmed using a real time PCR DNA test for the CEA
NHEJ1 7.8 kb deletion gene mutation (Laboklin GmbH
& Co.KG, 8304).
Using an analysis of the probands’ pedigree twenty other
dogs related to the affected female were subsequently
screened using the DNA test for the CEA mutation. Five
of these dogs were also examined clinically and CH lesions
were found in one, the dog’s dam. Here the small size of
lesions rendered a positive ophthalmoscopic diagnosis dif-
ficult (Fig. 2), demonstrating the value of litter screening
Fig. 2 The temporal area of the right fundus of the affected dam demonstrating a small area of choroidal hypoplasia
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diagnosis. However DNA testing confirmed the CEA diag-
nosis for this dog whilst eight others were shown to be
carriers for the disease (Fig. 3). Colobomatous lesions and
other possible features of CEA were not found in any of
these dogs.
Permission has been obtained from all the owners and
breeders whose dogs were involved in this study to record
and publish both the clinical findings and the DNA results.
Discussion and conclusions
This is the first report of CEA in the Australian Kelpie
breed, diagnosed on the basis of bilateral CH seen
ophthalmoscopically and confirmed by genetic testing.
The breed originated from British dogs imported into
Australia for stock work in the early nineteenth century.
They were simply described as collies or colleys, beforeFig. 3 Pedigree analysis of the 21 related Australian Kelpie dogs examined
the second line and asterisks mark the six dogs clinically examinedthe more traditional “collie” breeds were established.
This background indicated that CEA could be present in
the Kelpie and was the reason for this small study.CH le-
sions and the association with the CEA related NHEJ1
mutation could be reported,but colobomatous defects
and the other features of CEA were not seen in either of
the affected dogs. Further screening is required to evalu-
ate the prevalence of the NEHJ1 gene mutation in this
breed and breeders should be aware that in addition to
the use of the DNA test and the ophthalmoscopic exam-
ination of the breeding stock, litter screening at six to 8
weeks of age will identify both CH and possible colobo-
matous lesions. The existence of a “go normal” change
in which CH lesions can be masked by pigmentation be-
yond 12 weeks of age means that in adult dogs ophthal-
moscopic examination needs to be supported by DNA
testing to effect efficient disease control.on the survey. The subject of this case report is the affected dog on
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